Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1422 |
|---|---|
| Identifier | NCT03627052 |
| Trial Title | A Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Moderate to Severe Ulcerative Colitis |
| Interventions | DRUG: Itacitinib|DRUG: Placebo |
Participant Information
| Sponsor | Incyte Corporation |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-09-20 |
|---|---|
| Primary Completion Date | 2019-11-13 |
| Completion Date | 2019-11-13 |